These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1341473)

  • 1. Acute asphyxiation as a fatal complication in oral acenocoumarol therapy.
    Tributsch W; Ambach E
    Eur J Med; 1992 Oct; 1(6):380. PubMed ID: 1341473
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rare complication of oral anticoagulants].
    Panecka A; Jakubowska M
    Pol Tyg Lek; 1981 Aug; 36(34):1305-6. PubMed ID: 7335515
    [No Abstract]   [Full Text] [Related]  

  • 3. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blue toe syndrome during oral anticoagulant therapy with acenocoumarol.
    Fernández MA; Andreu R; Fortea JM; Aznar J
    Thromb Haemost; 2001 Apr; 85(4):743. PubMed ID: 11341514
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol).
    Pattacini C; Manotti C; Pini M; Quintavalla R; Dettori AG
    Thromb Haemost; 1994 Feb; 71(2):188-91. PubMed ID: 8191397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An unusual anticoagulant complication: total mammary necrosis].
    Födisch HJ; Ortli P
    Wien Klin Wochenschr; 1967 Sep; 79(37):675-7 passim. PubMed ID: 5591370
    [No Abstract]   [Full Text] [Related]  

  • 8. Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis.
    Pescatore P; Horellou HM; Conard J; Piffoux M; Van Dreden P; Ruskone-Fourmestraux A; Samama M
    Thromb Haemost; 1993 Apr; 69(4):311-5. PubMed ID: 8497841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Syncumar-induced necrosis following heparin-induced thrombocytopenia and thrombosis].
    Pósán E; Adi S; Szücs G; Rigó J; Boda Z
    Orv Hetil; 1995 Apr; 136(18):945-8. PubMed ID: 7739854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper airway obstruction by sublingual hematoma: a complication of anticoagulation therapy with acenocoumarol.
    González-García R; Schoendorff G; Muñoz-Guerra MF; Rodríguez-Campo FJ; Naval-Gías L; Sastre-Pérez J
    Am J Otolaryngol; 2006; 27(2):129-32. PubMed ID: 16500477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis].
    Alonso Martínez JL; Abínzano Guillén ML; Urbieta Echezarreta MA; Annichérico Sánchez FJ; Fernández Ladrón V; García Sanchotena JL
    An Med Interna; 2008 Jan; 25(1):4-8. PubMed ID: 18377187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A; Márk L
    Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current results of hemostasis research (protein C, protein S) and their effect on oral anticoagulant therapy in clinical practice].
    Gruber A; Domján G; Blaskó G; Rákóczi I; Petö I; Sas G
    Orv Hetil; 1985 Nov; 126(45):2759-64. PubMed ID: 2933622
    [No Abstract]   [Full Text] [Related]  

  • 16. Probable acenocoumarol-amoxycillin interaction.
    Soto J; Sacristan JA; Alsar MJ; Fernandez-Viadero C; Verduga R
    Acta Haematol; 1993; 90(4):195-7. PubMed ID: 8140860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced anticoagulant effect of coumarin derivatives induced by doxycycline coadministration.
    Caraco Y; Rubinow A
    Ann Pharmacother; 1992 Sep; 26(9):1084-6. PubMed ID: 1421670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.
    Mark L; Marki-Zay J; Fodor L; Hajdara I; Paragh G; Katona A
    Kardiol Pol; 2006 Apr; 64(4):397-402; discussion 403-4. PubMed ID: 16699986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients.
    Mazokopakis EE; Vrentzos GE; Ganotakis ES
    Curr Med Res Opin; 2003; 19(6):565-6. PubMed ID: 14594529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.